| Q40615748 | A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase |
| Q24323222 | Cloning and expression in vitro of human xanthine dehydrogenase/oxidase |
| Q77818246 | Effect of interferon-gamma on purine catabolic and salvage enzyme activities in rats |
| Q42234208 | Effects of 5-diazoimidazole-4-carboxamide and 3-diazopyrazole-4-carboxamide and related thioazo compounds on xanthine oxidase, uricase, and hypoxanthine-guanine phosphoribosyltransferase |
| Q43541759 | Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia |
| Q46263753 | Hydrocaffeic and p-coumaric acids, natural phenolic compounds, inhibit UV-B damage in WKD human conjunctival cells in vitro and rabbit eye in vivo. |
| Q39109285 | Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research. |
| Q33190294 | Interferons induce xanthine dehydrogenase gene expression in L929 cells |
| Q54105256 | Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease. |
| Q28574692 | Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant |
| Q33215516 | Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo |
| Q34302967 | Molecular variation in relation to purine metabolism |
| Q34812986 | Molybdenum enzymes in higher organisms |
| Q36744795 | Molybdenum(VI) salts convert the xanthine oxidoreductase apoprotein into the active enzyme in mouse L929 fibroblastic cells |
| Q39911624 | Nicotinamide and Liver Xanthine Oxdidase |
| Q38130310 | Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity? |
| Q44260361 | Protection against ultraviolet B-induced oxidative DNA damage in rabbit corneal-derived cells (SIRC) by 4-coumaric acid |
| Q40311205 | Purification and characterization of xanthine oxidase from livers of vitamin E deficient rabbits |
| Q43480749 | Reduction of the metallochromic indicators arsenazo III and antipyrylazo III to their free radical metabolites by cytoplasmic enzymes |
| Q52952815 | Role of Exogenous Melatonin on Cell Proliferation and Oxidant/Antioxidant System in Aluminum-Induced Renal Toxicity. |
| Q64229710 | Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP |
| Q53932059 | Surgical stress and the small intestine: role of oxygen free radicals. |
| Q73877065 | The conversion from the dehydrogenase type to the oxidase type of rat liver xanthine dehydrogenase by modification of cysteine residues with fluorodinitrobenzene |
| Q24531863 | The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme |
| Q54624275 | The regulation of rat liver xanthine oxidase: Conversion of type D (dehydrogenase) into type O (oxidase) by a thermolabile factor, and reversibility by dithioerythritol |
| Q72536377 | The structure of chicken liver xanthine dehydrogenase. cDNA cloning and the domain structure |
| Q53785444 | Two interconvertible forms of L-type pyruvate kinase from rat liver |
| Q35167513 | Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase |
| Q41173251 | Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties |
| Q39184316 | Xanthine oxidase activities: Evidence for two catalytically different types |
| Q50937465 | Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats. |